Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px
Organisation › Details

Velabs Therapeutics GmbH

Velabs Therapeutics is a spin-off company launched by Europe's most renowned institute for life sciences research, the European Molecular Biology Laboratory (EMBL) and its technology transfer arm EMBLEM Technology Transfer (EMBLEM). The institute has an outstanding track record in instrumentation development and is at the forefront of microfluidics-based screening technology and applications worldwide. The Company's droplet-based microfluidic screening technology is designed to rapidly generate antibodies against target molecules presented on cellular membrane surfaces or as a soluble protein. Velabs has pioneered the use of droplet microfluidics for the rapid screening of correctly paired human antibodies; the antibodies found by Velabs not only bind to a drug target, but can also modulate its function. *


Period Start 2017-12-21 established (s-off)
Period End 2021-05-21 merged
  Group Veraxa Biotech (Group)
  Today Veraxa Biotech GmbH (DE)
  Predecessor EMBL (European Molecular Biology Laboratory)
  Successor Veraxa Biotech GmbH (DE)
Products Industry microfluidics technology
  Industry 2 drug discovery
Person Person Antz, Cristoph (Veraxa Biotech 202106 Managing Director before Acousia Therapeutics + Elara + EMBL Ventures + Abeta)
Region Region Heidelberg
  Country Germany
  Street 1 Meyerhofstr.
  City 69117 Heidelberg
  Tel +49-6221-8194
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Velabs Therapeutics GmbH. (6/27/19). "Press Release: Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody Screening Programme". Heidelberg.
Record changed: 2021-06-14


Picture [iito] Plain Stupid Simple 650x80px

More documents for Veraxa Biotech (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture [iito] Back into Ad 650x80px

» top